Oncological outcomes of prostate cancer surgery

被引:3
作者
Soulie, M. [1 ]
Salomon, L. [2 ]
机构
[1] CHU Rangueil, Dept Urol Androl & Transplantat Renale, F-31059 Toulouse 9, France
[2] CHU Henri Mondor, Serv Urol & Transplantat Renale & Pancreat, F-94010 Creteil, France
来源
PROGRES EN UROLOGIE | 2015年 / 25卷 / 15期
关键词
Prostate cancer; Radical prostatectomy; Oncological outcomes; Positive surgical margins; Biochemical recurrence; Cancer-specific survival; Biochemical disease-free survival; ASSISTED RADICAL PROSTATECTOMY; LYMPH-NODE DISSECTION; POSITIVE SURGICAL MARGINS; TERM-FOLLOW-UP; STAGE D1 T1-3; HIGH-RISK; ANDROGEN-DEPRIVATION; LOCAL TREATMENT; RETROPUBIC PROSTATECTOMY; FUNCTIONAL OUTCOMES;
D O I
10.1016/j.purol.2015.07.015
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective. - Review of the oncological results of the radical prostatectomy as initial treatment of prostate cancer, according to the surgical approach and the risk stratification using D'Amico risk groups. Materials and methods. - Review of literature using Medline databases and MedScience based on scientific relevance. Research focused on the oncological results of the radical prostatectomy in series and meta-analysis published since 10 years, taking into consideration the surgical approach if mentioned. Results. - The characteristics of the operated tumor highly impact the local control authenticated by the pathologic stage and the rates of positive surgical margins (PSM), in addition to the survival and the biochemical recurrence. Surgical technique adapted according to the tumor treated, was a constant challenge to the urologist, who counter balance between the oncological control and the conservation of urinary and sexual function by conditioning the type of radical prostatectomy. Results of radical prostatectomy acceptable in terms of PSM and survival are not influenced by the surgical approach but by the degree of surgical experience. Conclusion. - Results of radical prostatectomy show the efficient local control of prostate cancer, taking into consideration the oncological rules and indications validated by multidisciplinary meetings, based on the national (CCAFU) and European oncological guidelines. Tendency is going toward considering radical prostatectomy indicated for patients with higher risk of disease progression, so integrating surgery in a multidisciplinary personalized approach. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1010 / 1027
页数:18
相关论文
共 122 条
[1]   Long-term Cancer Control Outcomes in Patients with Clinically High-risk Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Results from a Multi-institutional Study of 1100 Patients [J].
Abdollah, Firas ;
Sood, Akshay ;
Sammon, Jesse D. ;
Hsu, Linda ;
Beyer, Burkhard ;
Moschini, Marco ;
Gandaglia, Giorgio ;
Rogers, Craig G. ;
Haese, Alexander ;
Montorsi, Francesco ;
Graefen, Markus ;
Briganti, Alberto ;
Menon, Mani .
EUROPEAN UROLOGY, 2015, 68 (03) :497-505
[2]   More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer [J].
Abdollah, Firas ;
Gandaglia, Giorgio ;
Suardi, Nazareno ;
Capitanio, Umberto ;
Salonia, Andrea ;
Nini, Alessandro ;
Moschini, Marco ;
Sun, Maxine ;
Karakiewicz, Pierre I. ;
Shariat, Sharhokh F. ;
Montorsi, Francesco ;
Briganti, Alberto .
EUROPEAN UROLOGY, 2015, 67 (02) :212-219
[3]   Impact of Adjuvant Radiotherapy on Survival of Patients With Node-Positive Prostate Cancer [J].
Abdollah, Firas ;
Karnes, R. Jeffrey ;
Suardi, Nazareno ;
Cozzarini, Cesare ;
Gandaglia, Giorgio ;
Fossati, Nicola ;
Vizziello, Damiano ;
Sun, Maxine ;
Karakiewicz, Pierre I. ;
Menon, Mani ;
Montorsi, Francesco ;
Briganti, Alberto .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (35) :3939-U222
[4]   Predicting Survival of Patients with Node-positive Prostate Cancer Following Multimodal Treatment [J].
Abdollah, Firas ;
Karnes, R. Jeffrey ;
Suardi, Nazareno ;
Cozzarini, Cesare ;
Gandaglia, Giorgio ;
Fossati, Nicola ;
Bianchi, Marco ;
Boorjian, Stephen A. ;
Sun, Maxine ;
Karakiewicz, Pierre I. ;
Montorsi, Francesco ;
Briganti, Alberto .
EUROPEAN UROLOGY, 2014, 65 (03) :554-562
[5]   The Impact of Pathologic Staging on the Long-Term Oncologic Outcomes of Patients With Clinically High-Risk Prostate Cancer [J].
Abern, Michael R. ;
Terris, Martha K. ;
Aronson, William J. ;
Kane, Christopher J. ;
Amling, Christopher L. ;
Cooperberg, Matthew R. ;
Freedland, Stephen J. .
CANCER, 2014, 120 (11) :1656-1662
[6]   Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database [J].
Abern, Michael R. ;
Aronson, William J. ;
Terris, Martha K. ;
Kane, Christopher J. ;
Presti, Joseph C., Jr. ;
Amling, Christopher L. ;
Freedland, Stephen J. .
PROSTATE, 2013, 73 (04) :409-417
[7]   Randomized Comparison between Laparoscopic and Robot-Assisted Nerve-Sparing Radical Prostatectomy [J].
Asimakopoulos, Anastasios D. ;
Fraga, Clovis T. Pereira ;
Annino, Filippo ;
Pasqualetti, Patrizio ;
Calado, Adriano A. ;
Mugnier, Camille .
JOURNAL OF SEXUAL MEDICINE, 2011, 8 (05) :1503-1512
[8]   Assessing the extirpative quality of a radical prostatectomy technique: categorisation and mapping of technical errors [J].
Barre, Christian ;
Thoulouzan, Matthieu ;
Aillet, Genevieve ;
Nguyen, Jean-Michel .
BJU INTERNATIONAL, 2014, 114 (04) :522-531
[9]   High-Risk Prostate Cancer: From Definition to Contemporary Management [J].
Bastian, Patrick J. ;
Boorjian, Stephen A. ;
Bossi, Alberto ;
Briganti, Alberto ;
Heidenreich, Axel ;
Freedland, Stephen J. ;
Montorsi, Francesco ;
Roach, Mack, III ;
Schroder, Fritz ;
van Poppel, Hein ;
Stief, Christian G. ;
Stephenson, Andrew J. ;
Zelefsky, Michael J. .
EUROPEAN UROLOGY, 2012, 61 (06) :1096-1106
[10]  
Beauval JB, 2015, PROG UROL, V25, P370, DOI 10.1016/j.purol.2015.03.007